Thursday, September 24, 2020 11:30:39 PM
Note 11 - SUBSEQUENT EVENTS:
Management has reviewed events between June 30, 2020 to the date that the financials were issued, and the following events were significant for disclosure:
The Company has fully satisfied and paid in full all institutional notes included in the Annual Report. Additionally, there are no additional outstanding Warrants or Options applicable to the former Institutional note holders. The Company created an Advisory Board to assist with the projected growth and expansion of the Company's operations. The Advisory Board is comprised of David Ojeda, former Amazon Logistics Director; John Parks Trowbridge, MD, Kevin Harrington, former Shark Tank entrepreneur, and Steven Mandell, renowned Sports and Entertainment attorney. The Company leased an additional 22,0000 square foot production facility at 3151 Scott St., Vista, Ca. 92081 in close proximity to its 8,000 square foot corporate headquarters to accommodate increased production and distribution. The Company expanded its product line from its Solar Led marketing agreement to include ultraviolet and UV-C Personal Protection Equipment and commercial UV powered sterilization and disinfection products. The Company is adding new distributors globally to expand distribution and sales of the company's PPE (Personal Protection Equipment) UVC sterilization and disinfection products. The Company received patent pending status for both domestic and foreign filings (PCT) for UV-C -LED light technology integrated for use in cell phones and tablets. The Company previously projected product sales of approximately $4,000,000 for its 1st quarter ending September 30, 2020. The company estimates that it is currently on target to meet those projection
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM